《異動股》松齡護老(01989.HK)午後閃崩一度瀉67%創上市低 交投放量
松齡護老集團(01989.HK)今早(23日)平開報1.34元後,早市拉鋸,惟午後突插水式下跌最多約67%,低見0.44元,低於2017年2月中旬上市價0.69元,並創上市以來新低;屆今午2時48分,報0.6元,跌幅55%,成交激增至8,290.8萬股,涉5,211萬元。
公司本周初公布,就控股股東Pine Active Care 向潛在買家可能出售權益一事,磋商仍在進行,尚未就潛在交易訂立任何正式或具法律約束力的協議。Pine Active Care持有公司6.05億股,佔已發行股本66.99%。(da/t)~
阿思達克財經新聞
網址: www.aastocks.com
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.